A Novel, Site‐Specific N‐Linked Glycosylation Model Provides Mechanistic Insights Into the Process‐Condition Dependent Distinct Fab and Fc Glycosylation of an IgG1 Monoclonal Antibody Produced by CHO VRC01 Cells
Biotechnology and Bioengineering · 2025-04 · 122 (4) · 761-778
DOI: 10.1002/bit.28916 ↗At a glance
Journal article in Biotechnology and Bioengineering, published online on 2024-12-30. Written by Jayanth Venkatarama Reddy and 5 co-authors. Institution: Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware, USA. Major MEDLINE topics: Antibodies, Monoclonal, Immunoglobulin G, Immunoglobulin Fc Fragments, Immunoglobulin Fab Fragments. Cited 7 times so far (Crossref); 50 references. Funded by: FDA HHS, This research was funded by U.S. Food And Drug Administration, grant number DHHS-FDA-R01FD006588, grant number U01FD007695A. This research was also supported i….
Abstract (original language)
The CHO VRC01 cell line produces an anti‐HIV IgG1 monoclonal antibody containing N‐linked glycans on both the Fab (variable) and Fc (constant) regions. Site‐specific glycan analysis was used to measure the complex effects of cell culture process conditions on Fab and Fc glycosylation. Experimental data revealed major differences in glycan fractions across the two sites. Bioreactor pH was found to influence fucosylation, galactosylation, and sialylation in the Fab region and galactosylation in the Fc region. To understand the complex effects of process conditions on site‐specific N‐linked glycosylation, a kinetic model of site‐specific N‐linked glycosylation was developed. The model parameters provided mechanistic insights into the differences in glycan fractions observed in the Fc and Fab regions. Enzyme activities calculated from the model provided insights into the effect of bioreactor pH on site‐specific N‐linked glycosylation. Model predictions were experimentally tested by measuring glycosyltransferase‐enzyme mRNA‐levels and intracellular nucleotide sugar concentrations. The model was used to demonstrate the effect of increasing galactosyltransferase activity on site‐specific N‐linked glycan fractions. Experiments involving galactose and MnCl 2 supplementation were used to test model predictions. The model is capable of providing insights into experimentally measured data and also of making predictions that can be used to design media supplementation strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware, USA.
- School of Biochemical Engineering, Indian Institute of Technology (Banaras Hindu University), Varanasi, India.
- Delaware Biotechnology Institute, & Department of Biological Sciences, University of Delaware, Newark, Delaware, USA.
ORCID profiles: Jayanth Venkatarama Reddy, Sumit Kumar Singh, Kelvin H Lee, Marianthi Ierapetritou
Funding
- FDA HHS
- This research was funded by U.S. Food And Drug Administration, grant number DHHS-FDA-R01FD006588, grant number U01FD007695A. This research was also supported i…
Cite
APA
Reddy, J. V., Leibiger, T., Singh, S. K., Lee, K. H., Papoutsakis, E., & Ierapetritou, M. (2025). A Novel, Site‐Specific N‐Linked Glycosylation Model Provides Mechanistic Insights Into the Process‐Condition Dependent Distinct Fab and Fc Glycosylation of an IgG1 Monoclonal Antibody Produced by CHO VRC01 Cells. Biotechnology and Bioengineering, 122(4), 761-778. https://doi.org/10.1002/bit.28916
Vancouver
Reddy JV, Leibiger T, Singh SK, Lee KH, Papoutsakis E, Ierapetritou M. A Novel, Site‐Specific N‐Linked Glycosylation Model Provides Mechanistic Insights Into the Process‐Condition Dependent Distinct Fab and Fc Glycosylation of an IgG1 Monoclonal Antibody Produced by CHO VRC01 Cells. Biotechnology and Bioengineering. 2025;122(4):761-778. doi:10.1002/bit.28916
BibTeX
@article{Reddy2025,
author = {Reddy, Jayanth Venkatarama and Leibiger, Thomas and Singh, Sumit Kumar and Lee, Kelvin H and Papoutsakis, Eleftherios and Ierapetritou, Marianthi},
title = {A Novel, Site‐Specific N‐Linked Glycosylation Model Provides Mechanistic Insights Into the Process‐Condition Dependent Distinct Fab and Fc Glycosylation of an IgG1 Monoclonal Antibody Produced by CHO VRC01 Cells},
journal = {Biotechnology and Bioengineering},
year = {2025},
volume = {122},
number = {4},
pages = {761--778},
doi = {10.1002/bit.28916}
}
EUVIMED